Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFFIRM: PPC-06 in Moderate-to-Severe Plaque Psoriasis
NCT03421197Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jan 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tepilamide fumarate in plaque psoriasis, sponsored by Dr. Reddy's Laboratories. Started Jan 2018; status: completed.
02
Drugs
tepilamide fumarate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03421197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421197.